Leef Brands (LEEEF) EBITDA Margin (2025 - 2026)
Leef Brands (LEEEF) reported EBITDA Margin of 13.69% for Q1 2026, up 3399.0% on a YoY basis from 0.39% in Q1 2025, and up 167.45% sequentially from 20.3% in Q1 2025.
Leef Brands (LEEEF) EBITDA Margin (2025 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 2 years of EBITDA Margin data on file, last reported at 13.69% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn | 13.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.69% |
| Mar 31, 2025 | -20.30% |